152 related articles for article (PubMed ID: 1545128)
21. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
[TBL] [Abstract][Full Text] [Related]
22. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
Chatila T; Wood N; Parsonnet J; Geha RS
J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
[TBL] [Abstract][Full Text] [Related]
23. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
Tiedemann RE; Fraser JD
J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
[TBL] [Abstract][Full Text] [Related]
24. Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.
al-Daccak R; Mehindate K; Hébert J; Rink L; Mecheri S; Mourad W
Infect Immun; 1994 Jun; 62(6):2409-16. PubMed ID: 8188366
[TBL] [Abstract][Full Text] [Related]
25. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
26. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
27. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
28. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
29. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
30. Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma.
Adams H; Brummelhuis W; Maassen B; van Egmond N; El Khattabi M; Detmers F; Hermans P; Braam B; Stam J; Verrips T
Biotechnol Bioeng; 2009 Sep; 104(1):143-51. PubMed ID: 19475676
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcal superantigens as inducers of signal transduction in MHC class II-positive cells.
Mourad W; al-Daccak R; Chatila T; Geha RS
Semin Immunol; 1993 Feb; 5(1):47-55. PubMed ID: 8467095
[TBL] [Abstract][Full Text] [Related]
32. Zinc regulates cytokine induction by superantigens and lipopolysaccharide.
Driessen C; Hirv K; Kirchner H; Rink L
Immunology; 1995 Feb; 84(2):272-7. PubMed ID: 7751004
[TBL] [Abstract][Full Text] [Related]
33. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells.
Fuleihan R; Mourad W; Geha RS; Chatila T
J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171
[TBL] [Abstract][Full Text] [Related]
34. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
35. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
36. Separation of function between the domains of toxic shock syndrome toxin-1.
Wahlsten JL; Ramakrishnan S
J Immunol; 1998 Jan; 160(2):854-9. PubMed ID: 9551921
[TBL] [Abstract][Full Text] [Related]
37. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers.
Kühn U; Brand P; Willemsen J; Jonuleit H; Enk AH; van Brandwijk-Petershans R; Saloga J; Knop J; Becker D
J Immunol; 1998 Jan; 160(2):667-73. PubMed ID: 9551901
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
39. Agonist properties of a microbial superantigen peptide.
Pontzer CH; Griggs ND; Johnson HM
Biochem Biophys Res Commun; 1993 Jun; 193(3):1191-7. PubMed ID: 8323541
[TBL] [Abstract][Full Text] [Related]
40. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
Arad G; Hillman D; Levy R; Kaempfer R
J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]